| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $3.37 ▲ +2.03% | Yesterday | $3.27 ▼ -0.85% | Tomorrow's Editas Medicine Inc. Common Stock (EDIT) setup is anchored to $3.30 and targets $3.37 (+2.03%). The near-term read is upside; watch $3.40 / $3.20 because daily realized volatility is about 8.00%. |
Tomorrow's Editas Medicine Inc. Common Stock (EDIT) setup is anchored to $3.30 and targets $3.37 (+2.03%). The near-term read is upside; watch $3.40 / $3.20 because daily realized volatility is about 8.00%. | ||||
| Week | $3.51 ▲ +6.31% | Last Week | $3.21 ▼ -2.65% | The 7-day Editas Medicine Inc. Common Stock model moves from $3.21 to $3.51 (+6.31%). It gives upside momentum context for this stock, so breaks around $3.40 / $3.20 matter more than a single tick. |
The 7-day Editas Medicine Inc. Common Stock model moves from $3.21 to $3.51 (+6.31%). It gives upside momentum context for this stock, so breaks around $3.40 / $3.20 matter more than a single tick. | ||||
| Month | $3.74 ▲ +13.45% | Last Month | $3.11 ▼ -5.65% | The 1-month Editas Medicine Inc. Common Stock target is $3.74 (+13.45%), compared with the live reference near $3.30. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Editas Medicine Inc. Common Stock target is $3.74 (+13.45%), compared with the live reference near $3.30. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $4.10 ▲ +24.14% | Last Year | $2.97 ▼ -10.14% | The 1-year Editas Medicine Inc. Common Stock scenario points to $4.10 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Editas Medicine Inc. Common Stock scenario points to $4.10 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $4.92 ▲ +49.20% | 5 Years Ago | $2.62 ▼ -20.66% | The 5-year Editas Medicine Inc. Common Stock view is $4.92 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Editas Medicine Inc. Common Stock view is $4.92 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $3.30 | Mid |
| Daily Change | -7.56% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 74% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $3.30 | Daily Change | -7.56% |
| Market Cap | $322.98M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.